English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/124979
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


Physical exercise improves synaptic dysfunction and recovers the loss of survival factors in 3xTg-AD mouse brain

AuthorsRevilla, Susana ; Suñol, Cristina ; García-Mesa, Yoelvis ; Giménez-Llort, Lydia; Sanfeliu, Coral ; Cristòfol, Rosa
Keywords3xTg-AD mouse
Alzheimer's disease
GABA and NMDA receptors
Synaptic proteins
Voluntary exercise
Issue DateJun-2014
PublisherPergamon Press
CitationNeuropharmacology 81: 55-63 (2014)
AbstractPhysical exercise has become a potentially beneficial therapy for reducing neurodegeneration symptoms in Alzheimer's disease. Previous studies have shown that cognitive deterioration, anxiety and the startle response observed in 7-month-old 3xTg-AD mice were ameliorated after 6 months of free access to a running wheel. Also, alterations in synaptic response to paired-pulse stimulation were improved. The present study further investigated some molecular mechanisms underlying the beneficial effects of 6 months of voluntary exercise on synaptic plasticity in 7-month-old 3xTg-AD mice. Changes in binding parameters of [3H]-flunitrazepam to GABAA receptor and of [3H]-MK-801 to NMDA receptor in cerebral cortex of 3xTgAD mice were restored by voluntary exercise. In addition, reduced expression levels of NMDA receptor NR2B subunit were reestablished. The synaptic proteins synaptophysin and PSD-95 and the neuroprotective proteins GDNF and SIRT1 were downregulated in 3xTgAD mice and were recovered by exercise treatment. Overall, in this paper we highlight the fact that different interrelated mechanisms are involved in the beneficial effects of exercise on synaptic plasticity alterations in the 3xTg-AD mouse model. © 2014 Elsevier Ltd. All rights reserved.
Publisher version (URL)http://dx.doi.org/10.1016/j.neuropharm.2014.01.037
Identifiersdoi: 10.1016/j.neuropharm.2014.01.037
issn: 0028-3908
Appears in Collections:(IIBB) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.